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Abstract
Previous studies documented significant behavioral changes in the offspring of cocaine-exposed mothers. We now explore
the hypothesis that maternal cocaine exposure could alter the fetal epigenetic machinery sufficiently to cause lasting
neurochemical and functional changes in the offspring. Pregnant CD1 mice were administered either saline or 20 mg/kg
cocaine twice daily on gestational days 8–19. Male pups from each of ten litters of the cocaine and control groups were
analyzed at 3 (P3) or 30 (P30) days postnatum. Global DNA methylation, methylated DNA immunoprecipitation followed by
CGI
2 microarray profiling and bisulfite sequencing, as well as quantitative real-time RT-PCR gene expression analysis, were
evaluated in hippocampal pyramidal neurons excised by laser capture microdissection. Following maternal cocaine
exposure, global DNA methylation was significantly decreased at P3 and increased at P30. Among the 492 CGIs whose
methylation was significantly altered by cocaine at P3, 34% were hypermethylated while 66% were hypomethylated. Several
of these CGIs contained promoter regions for genes implicated in crucial cellular functions. Endogenous expression of
selected genes linked to the abnormally methylated CGIs was correspondingly decreased or increased by as much as 4–19-
fold. By P30, some of the cocaine-associated effects at P3 endured, reversed to opposite directions, or disappeared. Further,
additional sets of abnormally methylated targets emerged at P30 that were not observed at P3. Taken together, these
observations indicate that maternal cocaine exposure during the second and third trimesters of gestation could produce
potentially profound structural and functional modifications in the epigenomic programs of neonatal and prepubertal mice.
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Introduction
DNA methylation is a major mechanism for the maintenance of
epigenetic states [1,2]. Multiple studies have demonstrated that
DNA methylation, generally occurring preferentially at cytosine
residues, promotes chromatin repression which inhibits transcrip-
tion, whereas the absence of methylation is associated with the
formation of a chromatin state that is more permissive for
transcriptional activity [3–9]. DNA methylation has also been
implicated in mechanisms that increase genomic stability [8,10],
regulate the expression of parentally imprinted genes [11–13], or
provide for X chromosome gene dosage compensation in females
[14–17]. Deficits in DNA methylation in transgenic mice lacking
either maintenance DNMT1 (DNA methyltransferase1) or de novo
DNMT3a, DNMT3b result in lethality at specific stages of
development [18,19]. Perhaps most intriguing is the notion that
DNAmethylationmaycontributetotheregulationofdevelopmental
and adult gene expression or even that the phenomenon may be
capable of providing a memory mechanism for developmentally
established gene transcription levels [4,5,7,20–24].
Most of the methylated cytosines in mammalian genomes are
associated with CpG dinucleotides [25], although non-CpG
cytosines could also be methylated [26]. In most genomes, CpGs
are relatively under-represented and are found approximately
once per 80 dinucleotides. In 1–2% of the genome, however,
CpGs form so-called CGIs (CpG islands), which are regions of
DNA ranging in size from 200 bp to several kilobases that display
high C+G content of .55% and increased CpG frequency with an
observed/expected ratio of .0.6 [27]. The mouse genome, for
instance, contains ,37,000 CGIs [28,29]. A large number of
CGIs is associated with the promoters of housekeeping as well as
tissue-specific genes [28]. It has been speculated that these CGIs
represent memory ‘‘footprints’’ of embryonic gene replication that
could influence future gene activation [30]. The possibility that
neuroactive xenobiotics such as drugs of abuse could influence or
disrupt the memory function of these ‘‘footprints’’ as part of their
neurotoxic mechanisms should merit thorough investigation. The
present study explored this idea using cocaine as a test agent.
Employing a mouse model of prenatal cocaine exposure, we
examined the ability of maternal cocaine exposure to affect DNA
methylation in hippocampal pyramidal cells of the offspring.
Hippocampal neurons were chosen for this study because cocaine-
induced neurochemical, morphological, and physiological alter-
ations in this brain structure have been well documented [31–35].
PLoS ONE | www.plosone.org 1 April 2008 | Volume 3 | Issue 4 | e1919We examined whether chronic maternal cocaine treatment resulted
in changes in global DNA methylation or expression of DNMTs in
offspring pyramidal neurons on postnatal day 3 (P3). CGIs in the
DNA of hippocampal pyramidal neurons were profiled for drug-
induced alteration in their methylation state, followed by detailed
analysis of methylated CpGs in ten selected gene promoters. The
stability of cocaine-related changes at P3 was investigated by re-
examining the methylation indices in P30 littermates of the assessed
neonates. The findings indicate a strong association between
maternal cocaine exposure and significant alterations in global
DNA methylation, in CGI-specific methylation, and in the
transcriptional activities of several genes some of which are known
to code for proteins involved in critical neural functions.
Results
Cytoarchitecture, Microdissection, and DNA Content of
Hippocampal Pyramidal Layers
Qualitative visual analysis of images of coronal histological
sections through the hippocampus of the P3 and P30 male
offspring of saline-control and cocaine-treatment mothers revealed
no inter-group differences at either age. The shape of the entire
hippocampal structure was similar between the control and
treatment groups on all sections cut at comparable levels.
Pyramidal layers had sharp borders without cellular dysplasia.
The striata oriens and radiatum showed no abnormal cellular
densities or unusual cellular aggregations (Fig. 1a, b).
At both P3 and P30, the estimated total DNA content of the
hippocampal pyramidal layer showed no significant differences
between the male offspring of saline-control and cocaine-treated
mothers (Fig. 1c). Overall, the DNA content of the hippocampal
pyramidal layer at both ages ranged from 9.6 to 13.7 mg. The
intra-specimen coefficient of error values for the measured DNA
content of all the examined hippocampal pyramidal layers were
below 0.06 (Fig. 1c), indicating acceptable levels of precision [36].
Shown in Fig. 2 are micrographs of a section through the
hippocampus before and after laser microdissection of the
pyramidal layer. Examination of the section showed clean cut
lines that adhered to the outline of the pyramidal layer with
minimal tissue damage beyond the line of cut. The high quality of
nucleic acids extracted from the dissected tissues, based on the
NanoChip analysis results, further confirms the quality and
integrity of the laser-excised tissues.
Validation of the MeDIP Assay
The ability of the MeDIP procedure to generate a signal that
varies linearly with the number of methylated cytosines in a test
DNA sample is crucial to the utility of the assay. To verify that the
products of the MeDIP procedure are quantitatively proportional
to the content of methylated cytosines in assayed samples, we
tested four DNA fragments of similar lengths but containing
different numbers of CpGs (see selected targets and corresponding
primer sequences in Table 1). As shown in Fig. 3, densitometric
values generated from the assay were directly proportional to the
number of CpGs in the DNA fragments. This, thus, confirms the
linearity of the MeDIP assay as applied in our laboratory for the
present studies.
Effects of Maternal Cocaine Administration on Global
DNA Methylation and DNMT Expression in the
Hippocampal Pyramidal Layer of P3 Pups
We compared global DNA cytosine methylation as well as
DNMT1, DNMT3a, and DNMT3b expression levels in hippo-
Figure 1. Evaluation of the structure and total DNA content of
hippocampal pyramidal tissues in P3 progeny of saline-treated
and cocaine-treated mice. (a) Typical micrograph of HistoGene-
stained coronal section through the hippocampus of a P3 Saline pup.
(b) Micrograph of a comparable section from an age-matched offspring
of a cocaine-treated mother. (c) Relative amounts of total DNA content
between the offspring of saline-treated and cocaine-treated mothers at
P3 and P30. Horizontal bars show mean difference in DNA content
between Cocaine and Saline groups at each age, while vertical bars
show the SEM (n =10/group/age). For either age group, the inter-
sample ranges of coefficient of error (CE) values are provided at the
bottom of the chart. C1, C2, C3, hippocampal regions; DG, dentate
gyrus. Note the absence of detectable histological differences between
micrographs a and b.
doi:10.1371/journal.pone.0001919.g001
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females compared with matched pups from saline-control dams.
Shown in Table 2 are the sequences for the PCR primers and
probes used for the analysis of the methyltransferases and the
internal standards GAPDH and ß-actin. There was a significant
decrease of approximately 30% in the global DNA methylation
levels of cocaine-treatment P3 pups compared to matched saline
controls (Fig. 4a). However, this decrease in global DNA
methylation was not accompanied by changes in the expression
levels of DNMT1, DNMT3a or DNMT3b (Fig. 4b). The lack of
inter-group differences in DNA methyltransferase expression was
independent of our use of either GAPDH or ß-actin as internal
standards.
Profiles of CGI Methylation in Hippocampal Pyramidal
Tissues of P3 Pups
MeDIP+CGI array-based analysis was undertaken to compare
CGI methylation rates in hippocampal pyramidal tissues of male
P3 pups from cocaine-treated pregnant females and their matched
Figure 2. Histology of hippocampal sections before and after
laser microdissection. Photomicrograph of a typical HistoGene-
stained coronal section through the hippocampus of a 3-day-old mouse
(a), and the same section following excision of the hippocampal
pyramidal layer by microdissection on a Leica ASLMD laser capture
microdissection system (b). HIPpl, hippocampal pyramidal layer; DG,
dentate gyrus; SUB, subiculum. Note the precision of the cut.
doi:10.1371/journal.pone.0001919.g002
Figure 3. Relationship between the pixel density of MeDIP-
generated signals and the number of methylated CpGs present
in test DNA fragments of similar size (449, 446, 440, 445, and
449 bp) but containing different numbers of methylated CpGs
(0, 11, 25, 36, or 45, respectively). Each data point represents the
mean6SEM values for 3 clones. The linear regression line was fitted
using GraphPad Prism software. Note the linearity of the plotted
relationship, indicating that the MeDIP assay can quantitatively detect
the number of methylated CpGs within a DNA fragment.
doi:10.1371/journal.pone.0001919.g003
Table 1. PCR probes used in verification of the linearity of
MeDIP-based methylcytosine detection.
Target
Forward (F:) and Reverse
(R:) primers
446 bp fragment of UHNmmCPG0000038 CGI
(contains 11 CPGs)
F: CAGGGTCTGTAGCAGGA
R: TACCTCACGGCCCCAA
440 bp fragment of UHNmmcpg0007265 CGI
(contains 25 CPGs)
F: ACCACTTTCCGTCCTCA
R: CTTCTGCTGTCGCTGA
445 bp fragment of UHNmmcpg0000001 CGI
(contains 36 CPGs)
F: GACCTAAATGTGGTGGA
R: CTGGAGCGTTCCCGAA
449 bp fragment of UHNmmcpg0007250 CGI
(contains 45 CPGs)
F: CGGAATCAGCGGGGAA
R: CCCAAAAGGTCAGAAGGA
doi:10.1371/journal.pone.0001919.t001
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were observed for 492 CpG islands (Fig. 5). Among the affected
CGIs, 34% were hypermethylated (166 CGIs), while 66% were
hypomethylated (327 CGIs) in the offspring of cocaine-exposed
mothers. Further examination revealed that 93 CGIs having
altered methylation states (19% of the affected CGIs) were
associated with gene promoters (Fig. 4). Among these promoter-
associated CGIs, 31% were hypermethylated and include CGIs
associated with the promoters of 5 neural and 24 housekeeping
genes; the 69% that were hypomethylated include CGIs associated
with the promoters of 7 neural and 57 housekeeping genes. Exons
were associated with 27% of the affected CGIs (134 CGIs); 37% of
these CGIs were hypermethylated, while 63% were hypomethy-
lated. Introns were associated with 9% of the CGIs with altered
methylation states (44 CGIs); 61% of these were hypermethylated,
and the remaining 39% were hypomethylated (Fig. 4). Repetitive
elements, including members of the transposon families of LINE
(long interspersed nuclear elements) such as L1, SINE (short
interspersed nuclear elements) such as Alu, B2 and B4, and LTR
(long-terminal repeat)-containing elements such as ERV1, ERVK,
MaLR (described in [37]), as well as largely centromeric low
complexity and simple repeats (described in [38]) were associated
with 201 CGIs with altered methylation states in the offspring of
cocaine-treated mice (41% of all affected CGIs). Among these
CGIs, 36% were hypermethylated, and 64% were hypomethy-
lated. The numbers of hypermethylated and hypomethylated
CGIs containing specific frequently-encountered repetitive ele-
ments are given in Figure 5. For 98 of the CGIs with altered
methylation states in the cocaine-treatment group (20% of total
affected CGIs), however, we were unable to ascertain association
with any recognizable genomic elements.
Detailed CpG Methylation Analysis of Selected Promoters
Associated with Hypermethylated or Hypomethylated
CGIs and the Expression Levels of Genes Associated with
these Promoters
This part of the study was aimed at verifying and further
specifying the results of the foregoing MeDIP/CGI array-based
methylation profiling analyses. Bisulfite sequencing analysis with
evaluation of the expression levels of the linked genes was applied
to 10 promoters selected from among those that were found from
the high-throughput MeDIP/CGI profiling step to be associated
with CGIs that displayed abnormal cocaine-induced methylation
states. The identities of the genes associated with the selected
promoters as well as the primers and probes used in bisulfite
sequencing and in real-time PCR quantification of expressed
mRNAs are shown in Table 3. First selected were the promoters
for 4 genes that were potentially associated with hypermethylated
CGIs in P3 offspring of cocaine-exposed mice. These included
Figure 4. Global DNA methylation and DNMT expression levels
in the hippocampal pyramidal layer of P3 offspring from
saline-injected or cocaine-treated dams. (a) Global levels of
cytosine methylation in DNA samples of control and cocaine groups
each expressed as percentage relative to the methylation signal in
Epigentek’s methylated DNA standard. (b) Expression levels of DNA
methyltransferases DNMT1, DNMT3a, and DNMT3b each calculated as a
ratio relative to GAPDH as internal standard. Similar results were
obtained with ß-actin used as internal standard. Each column
represents mean6SEM of 10 samples. *p,0.05 compared to the
saline-control group.
doi:10.1371/journal.pone.0001919.g004
Table 2. PCR primers and probes used for analysis of DNA methylases and as internal controls.
Target Forward (F:), reverse (R:) primers and probes (Pr:)
DNA methylase 1 (DNMT1) F: GAGAACGGAACACACACTCTCACT
R: TATTTGAGTCTGCCATTTCTGCTC
Pr: 6FAM-AAGCCAACGGTTGTCCCGCCA-TAMRA
DNA methylase 3a (DNMT3a) F: CCATTCGACCTGGTGATTGG
R: CGCGCATCATGCAGGA
Pr: 6FAM-TGCAATGACCTCTCCATTGTCAACCCT-TAMRA
DNA methylase 3b (DNMT3b) F: AGCATCGTCTTCAGCAAGCA
R: TATCCATACCCTCCTGATCTCCAT
Pr: 6FAM-TCATCCCCTGCCAGCGTCGAC-TAMRA
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) F: CATGGCCTTCCGTGTTCCTA
R: TGCTTCACCACCTTCTTGATGT
Pr: 6FAM-CCCCAATGTGTCCGTCGTGGATC-TAMRA
ß-actin F: ACGGCCAGGTCATCACTATTG
R: CAGGATTCCATACCCAAGAAGG
Pr: 6FAM-ACGAGCGGTTCCGATGCCCTG-TAMRA
doi:10.1371/journal.pone.0001919.t002
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(polo-like kinase 2), PTPN5 (protein-tyrosine phosphatase non-
receptor type 5), and MAPK1(MAP Kinase 1). The promoters of
the other 6 genes were likely associated with hypomethylated CGIs
in P3 pups of cocaine-treated mice. These genes encode COQ7
(coenzyme Q7), DYRK3(dual-specificity tyrosine (Y)-phosphory-
lation-regulated kinase 3), GATA 4 (GATA binding protein 4),
GTF3c1(subunit 1 of general transcription factor 3c), IMPA1
(inositol (myo)-1-monophosphatase), and MPAT6(microtubule-
associated protein 6). Analysis of the methylograms derived from
bisulfite sequencing suggested that methylated CpGs were present
in the majority of the clones for all 10 promoters from samples of
both study populations (Fig. 6).
Now, clones of promoters linked to COQ7, DYRK3, GATA4,
GTF3c1, IMPA1, and MTAP6 from the pups of cocaine-treated
mice contained clearly lower proportions of methylated CpGs
than the parallel clones from the offspring of saline-control animals
(Fig. 6 and Table 4). This inference is supported by the
quantitative comparative analysis of the percentage of methylated
CPGs in the clones for these promoters between the two treatment
groups (6–14 fold, depending on the promoter). In contrast, visual
observation as well as statistical evaluation of methylograms of the
clones for GPR73, MAPK1, PLK2, and PTPN5-linked promoters
demonstrated a significant increase in CpG methylation associated
with cocaine exposure (4–12 fold, depending on the promoter;
Fig. 6). These observations are in general agreement with the
findings from the CGI methylation profiling experiment, which
served as a basis for the selection of the promoters for the bisulfite
sequencing analysis.
To evaluate whether the observed differences in the levels of
methylation in the bisulfite sequenced promoters would translate to
differential levels of expression of the linked genes, we resorted to
quantitative PCR analysis. This analysis showed that cocaine-
induced hypermethylation corresponded to a significant decrease in
the expression of GPR73, PLK2 and PTPN5 genes (5–13 fold,
depending on the gene; Table 4), while cocaine-induced promoter
hypomethylation corresponded to a significant increase in the
expression of DYRK3, GATA4, GTF3c1 and MTAP6 genes (4–
19 fold, depending on the gene; Table 4). Nevertheless, neither
hypermethylation of the promoter for MAPK1 nor hypomethylation
of the promoter for IMPA1 wasassociated withsignificant alterations
in the expression of these genes (Table 4). Similar inferences were
reached irrespective of whether the levels of genes of interest were
normalized against GAPDH or ß-actin as internal standards.
Figure 5. Genomic characteristics of abnormally methylated CGIs in the hippocampal pyramidal layer of P3 cocaine-treatment
pups. Information associating abnormally methylated CGIs with various genomic elements was obtained by BLAT analysis of the affected CGIs as
determined from the MeDIP/CGI array profiling experiments. The data is limited to the genomic elements that are present in at least 5 CGIs. The
number of CGIs associated with a particular genomic element is represented by horizontal bars across from the element’s name. The length of the
bar is proportional to the number of CGIs; this number is also given at the end of the row. The number of CGIs with sequences matching more than
one position in the genome is provided in parenthesis. The tendency for CGIs to be associated with more than one genomic element is reflected in
the partial overlap of the bars on most rows. Note that overall there are more hypomethylated CGIs than hypermethylated CGIs.
doi:10.1371/journal.pone.0001919.g005
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Targets
Nested PCR primers used in bisulfite
sequencing of CGI-associated promoters
Real-time PCR TaqMan primers and probes for
mRNA quantification
G-protein coupled receptor 73 (GPR73; PRK1) 1) F1-R1, 879 bp; 2) F2-R1, 790 bp.
F1: TATTTGGAAATTTGGTTATGTTGTT F: GGCATCGGCAACTTCATCTT
R1: CCCTAATCTTTCCTAAAATTATTCTC R: CGATAAGCAGGTTGGTGAGGTT
F2: GGAAATTTGGTTATGTTGTTGAGTAG Pr: 6FAM-CACTGCCCTGGCCCGCTACAA-TAMRA
Polo-like kinase 2 (PLK2) 1) F1-R1, 700bp; 2) F2-R1, 600bp.
F1: GTTGTTTTGGTTTTGTTTGGTG F: GCAAGAGTCCTTCGAGGATGTC
R1: AACTACCCATCTTCAAAAAACTACTAC R: CGAGAGCTGGTACCCAAAGC
F2: ATGATAGGGTGTGGGGTTGTATATA Pr: 6FAM-TCCCCAAAGAGCAGCTGAGCACGT-TAMRA
Protein-tyrosine phosphatase non-receptor type 5
(PTPN5; STEP)
1) F1-R1, 704bp; 2) F2-R1, 612bp.
F1: GGGGTGAAATGTTAGGAATAAGTTT F: AGTGCAGGGATTGGGAGAACT
R1: AAACCCTTAACATAAAATCCCATCT R: ACTGTTCGCATGTCTGGATCAT
F2: GTTGGAATTATTTTTTTTAGTAGT Pr: 6FAM-CTGCTTCATTGCCACCAGCATCTGC-TAMRA
Mitogen activated protein kinase 1 (MAPK1) 1) F1-R1, 855 bp; 2) F2-R1, 780 bp. F: CCACCCATACCTGGAGCAGTA
F1: GGTTGGTGTGTAGTGAGTTTTTTG F: CCACCCATACCTGGAGCAGTA
R1: CCCCAAAACTCCAAAAATAAAA R: TCGTCCAACT CCATGTCAAACT
F2: AGTATTAGGATAGTGGGTGGGATTT Pr: 6FAM-TGAGCCCATTGCTGAAGCGCC-TAMRA
Coenzyme Q7 (COQ7) 1) F1-R1, 857 bp; 2) F2-R1, 749 bp.
F1: GATTTTAGTTGTTATATTAATGGATATGT F: GGAGCTTGAACACCACGATACA
R1: ACAAAACATCCTACAAAAATTCACC R: CTGCATCCGGCCTGGATA
F2: TTATGAATAATTTAGTAAAGGATGAATAA Pr: 6FAM-AGCTGGCTCCCGCGTATGCCTT-TAMRA
Dual-specificity tyrosine phosphorylation regulated
kinase 3 (DYRK3)
1) F1-R1, 800 bp; 2) F2-R1, 753 bp.
F1: TTTGTAGTTTTAGGAAATTTGATGG F: CCTGGACGCTCTGCACAA
R1: ATCTCTACTACTCCACCCCAAAAC R: GCTGGAGCCAAAGTCGATGA
F2: TTTTTTTTATTTTTATTTTAATTGT Pr: 6FAM-ACACCACGGCCGAAGCGCC-TAMRA
GATA binding protein 4 (GATA4) 1) F1-R1, 753 bp; 2) F2-R1, 636 bp.
F1: GTTTTGTGATTGTTTTATTAATTTTTAGAT F: CCCACTCTGGAGGCGAGAT
R1: CCCAACAAACAAAATCCATAC R: CCGGTTGATGCCGTTCAT
F2: TTTATTTTTATTTTAGGGAAGGAATTATAG Pr: 6FAM-ACCTGTGCAATGCCTGTGGCCTC-TAMRA
General transcription factor IIIc subunit 1 (GTF3c1;
TFIIIc220)
1) F1-R1, 861 bp; 2) F2-R1, 858 bp.
F1: ATTATTTTAAAGGATTGTTGTGAAA F: GTTTTTGTGGCGGGCTTTAG
R1: TTCCAAAAACAATAAAAAAACAAAC R: AGTCGATTTCTTCATACCGGTCTT
F2: ATTTTAAAGGATTGTTGTGAAA Pr: 6FAM-CACGCACCCGGGCATCAGTTTCTAC-TAMRA
Inositol (myo)-1-monophosphatase 1 (IMPA1) 1) F1-R1, 707 bp; 2) F2-R1, 421 bp.
F1: TGAGAGTGTTTAATGATAGTTATAATTTTA F: GGAGGAGCAGATGCCTATTATGA
R1: AAACCCTAAAAACTTAAACAAAACC R: ACGGTCCACCCGTGACAT
F2: GGATTAGTTTTTATAAAGGTAAATT Pr: 6FAM-TGATGCCAGCTCCCGCCATGT-TAMRA
Microtubule-associated protein 6 (MTAP6; STOP; MAP6) 1) F1-R1, 757 bp; 2) F2-R1, 572 bp.
F1: TTAGTATTTGGGAGGTAAAGGTAGG F: CCCGACGACAAGGAGCAA
R1: CAAAAAAACTATAAACTTAAACCATAAC R: GGACCTCGGTTCTTAGATGCAT
F2: TTTGAAATAGATATTTTATGGAG Pr: 6FAM-AGAGAGCCGGGTCAAACCCACCA-TAMRA
For the nested PCR, the first row for each gene depicts the primers used in the first and second steps of the nested PCR with the size of the expected amplicons.
Common abbreviated names of the target genes are shown in parentheses. F1 and F2, forward primers; R1, reverse primer; Pr, probe.
doi:10.1371/journal.pone.0001919.t003
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PLoS ONE | www.plosone.org 6 April 2008 | Volume 3 | Issue 4 | e1919Figure 6. CpG methylograms of selected abnormally methylated promoters in P3 mice. From the MeDIP/CGI array-generated methylation
profiles, ten cocaine-induced abnormally methylated CGIs known to be associated with gene promoter regions were selected and cloned, followed
by bisulfite sequencing to identify the relative locations of methylated CpGs in the gene promoter sequence. For each chart, the name of the
promoter is shown on the left vertical while the horizontal numbers mark the CpGs on the sequence; the CpGs are numbered from the 5’end of the
clone. The vertical numbers on the right (1–5) indicate data rows for samples from each of 5 animals from the control (upper, DRN) and cocaine
(lower, COC) groups. For each sample, three clones were sequenced, hence the three sub-rows available to each sample for methylation mapping.
For each sub-row representing a clone, white squares indicate unmethylated CpGs while black-filled squares indicate methylated CpGs. If all three
clones were consistent, the filled boxes would appear for each sub-row for that sample. If all 5 samples (mice) were consistent, then the filled boxes
would extend vertically across all 5 rows. The relative density of filled boxes between the control (upper 5) samples and the cocaine (lower 5) samples
provides a visual feedback on the relative levels of CpG methylation in these DNA regions. For example, clones of DYRK3 or COQ7 promoters
contained lower proportions of methylated CpGs in the cocaine-treatment pups than in the saline-control offspring, whereas the converse applies in
the case of GPR73 or MAPK1 clones.
doi:10.1371/journal.pone.0001919.g006
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Among P3 and P30 Offspring of Control and Cocaine-
Treated Mothers
We re-examined global DNA methylation, DNMT expression
levels, and CGI methylation in hippocampal pyramidal tissues of
30-day-old brothers of the P3 mice used in generating the
preceding data. In contrast to our findings in neonatal animals, we
observed a significant elevation of approximately 35% in global
DNA methylation in P30 offspring from cocaine-treated mothers
compared to P30 offspring of saline-controls (Fig. 7a). Further-
more, this increase was accompanied by notably elevated
expression levels of DNMT1 (by ,30%) and DNMT3a (by
,60%; Fig. 7b). No differences in the expression levels of
DNMT3b were noted (Fig. 7b). DNMT expression data were
similar whether analyzed with GAPDH or ß-actin as internal
controls.
MeDIP/CGI array-based profiling of hippocampal DNA
samples of P30 mice detected altered methylation states for 278
CGIs in the cocaine-treated group compared to controls. This
total number of altered CGIs is 42% fewer than the corresponding
number in P3 animals (Fig. 8a). Among the CGIs with altered
methylation states in P30 progeny of cocaine-treated mice, 59%
(163 CGIs) were hypermethylated, and 41% (115 CGIs) were
hypomethylated (Fig. 8a). Also, 67% of the CGIs (186 CGIs),
which showed changes in methylation state in P30 cocaine group,
corresponded to CGIs affected in P3 animals. However, 80 of
these CGIs (43%) showed reversal in the direction of change: 4
previously hypermethylated CGIs became hypomethylated, and
76 previously hypomethylated CGIs became hypermethylated
(Fig. 8a). In addition, 92 CGIs showed cocaine-related alterations
in methylation state only in P30 animals (33% of the total number
of the CGIs affected at this age). Among the newly altered CGIs,
73% were hypermethylated, while 27% were hypomethylated
(Fig. 8a).
At P30, 77 CGIs with altered methylation state (28% of the total
number of the affected CGIs) in the male offspring of cocaine-
treated mice overlapped with gene promoters, which is 17% fewer
promoter-associated CGIs than were detected at P3 (Fig. 8b).
Among the promoter-associated CGIs in the DNA of P30 cocaine
animals, 45% were hypermethylated (this includes CGIs associat-
ed with promoters of 9 neural and 26 housekeeping genes), and
55% (42) were hypomethylated (this includes CGIs associated with
promoters of 2 neural and 40 housekeeping genes). Eighty-two
percent of the promoter-associated CGIs showing altered
methylation state at P30 (63 CGIs) were also present among the
affected CGIs at P3. Among the latter CGIs, 39% (32 CGIs)
reversed the direction of change: 8 previously hypermethylated
CGIs became hypomethylated, while 24 previously hypomethy-
lated CGIs became hypermethylated. At P30, 7 novel promoter-
associated CGIs were hypermethylated, and 7 novel promoter-
associated CGIs were hypomethylated. Further, 37% of the
Table 4. Comparison of the MeDIP/CGI array profiling-defined methylation states of promoter-associated CGIs, promoter bisulfite
sequencing-derived percentages of methylated CpGs, and RT-PCR-based expression levels for 10 selected genes between the
hippocampal pyramidal layer of 3-day-old male offspring of saline-control mothers and the corresponding tissue of parallel pups
born by cocaine-treated females.
Genes with CGI-
containing promoters
CpG methylation of promoter-associated
CGIs (MeDIP/CGI array profiling) log2
(cocaine/saline) 6SEM
CpG Methylation of promoter-
associated CGIs (Bisulfite sequencing)
log2 (cocaine/saline)6SEM
mRNA Expression of CGI-
containing promoters (Real-time
RT-PCR) log2 (cocaine/saline) 6SEM
GPR73 0.9360.07* 1.7960.30
* 21.6660.43
*
PLK2 1.2360.10
* 2.6960.47
* 22.0960.23
*
PTPN5 1.0360.03
* 2.5260.03
* 22.5660.33
*
MAPK1@ 1.3060.03
* 2.3960.03
* 0.2060.20
COQ7 21.4960.03
* 21.4060.40
* 0.2760.33
DYRK3 21.2660.07
* 21.3360.43
* 1.4360.20
*
GATA4 26.4160.01
* 21.6360.17
* 2.9660.37
*
GTF3c1 22.8660.01
* 22.5260.17
* 1.7360.27
*
IMPA1 22.3360.01
* 22.1360.30
* 0.3760.43
MTAP6@ 0.9360.07
* 21.8960.03
* 2.3660.20
*
@Neural tissue-specific gene.
*p,0.05; comparing the corresponding cocaine and saline groups (each comprising ten liters).
doi:10.1371/journal.pone.0001919.t004
Figure 7. Effects of maternal cocaine exposure on global DNA
methylation and DNMT gene expression in 30-day-old pups.
(a) Relative levels of global DNA methylation in hippocampal pyramidal
tissues of P30 pups. Each bar represents the mean6SEM (n=10).
*p,0.05 compared to saline-control group. (b) Expression levels of
DNA methyltransferases relative to GAPDH as internal standard.
*p,0.05 compared to the respective saline-control group.
doi:10.1371/journal.pone.0001919.g007
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those CGIs were hypermethylated (this is 49% fewer CGIs than at
P3; Fig. 8c), while 38 were hypomethylated (this is 48% fewer
CGIs than at P3; Fig. 8c). Thus, exposure of female mice to
cocaine during pregnancy resulted in multiple alterations in the
methylation states of offspring DNA, and some of these cocaine-
related effects could persist through at least the prepubertal period
of 30 days postnatum.
Discussion
It is now widely believed that epigenetic phenomena contribute
significantly to guiding mammalian development [7,20,39–42].
For instance, epigenetic mechanisms have been implicated in the
programming of cell fate and differentiation [43–50], in defining
ultimate activity levels of specific functional systems [22,24], and in
mediating environmental modulation of genetically-based devel-
opmental programs [22,24,42,51,52]. Indeed, the latter function
probably subserves a unique biological role in enabling the
formation of the phenotype that is best adapted for organismal
survival and reproduction under the living conditions that are
dictated by the developmental environment [52,53]. Relatively
easy environmental access to the developmental and reproductive
machinery of a complex organism, however, could increase the
organism’s susceptibility to the adverse effects of abnormal
prenatal and/or neonatal exposures to various chemical and
biological toxicants [20,23,54–58]. This study demonstrates that
maternal cocaine use could produce significant changes in the
regulation of various offspring genes that may be involved in
diverse functional systems. The study observed cocaine-related
alterations in the expression of the DNA methyltransferases,
DNMT1 and DNMT3b, in hippocampal pyramidal cells of pups
from cocaine-exposed mothers. This observation is in agreement
with, and extends, our earlier report on the ability of chronic
cocaine exposure to affect the cellular levels of these two
methyltransferases in the spermatocytes of adult male mice
chronically exposed to cocaine [59]. Thus, parental exposure to
cocaine, at least in the case of pregnant females, could have
significant genomic and functional consequences upon the offspring.
The MeDIP procedure combined with CGI microarray
technology enabled us to reliably and efficiently profile the
methylation states of a wide range of CpG islands in multiple
samples. By enriching the samples for CGIs prior to methylation
analysis, we were able to focus on those regions of the DNA that
are more likely to be associated with the regulatory sequences of
various genes. Thus, many of the 492 CGIs that showed altered
methylation in response to maternal cocaine exposure were found
to be associated with the promoter regions of one or more genes.
Among the ten altered CGIs that were selected for confirmation
and detailed analysis by bisulfite sequencing, four were hyper-
methylated. These contained genes encoding G-protein-coupled
receptor-73 which is a Gq-associated receptor for prokineticin that
functions to support neuronal survival in the central nervous
system [60], polo-like kinase2 which is known to promote cell
proliferation and to participate in dendritic spine degradation
[61,62], protein-tyrosine phosphatase non-receptor type5 which is
a neural tissue-specific dopamine D1/NMDA receptor-regulated
tyrosine phosphatase involved in suppressing mitogen activated
kinase cascades and blocking long-term potentiation [63], and
MAP kinase1 which mediates extracellular signal-regulated
intracellular cascades involved in cell differentiation and survival
and in neuronal dendritic development and synaptic plasticity
[64,65]. The six genes whose promoter regions were found in
hypomethylated CGIs include those encoding coenzyme Q7
Figure 8. Effects of maternal cocaine exposure on CGI DNA methylation in P30 compared to P3 pups. (a) Cocaine-induced
hypermethylated and hypomethylated CGIs in P30 compared to P3 pups. Shown are the numbers of CGIs with altered methylation levels in cocaine-
treated animals relative to saline-controls at each age. For P30 data, the number of CGIs with altered methylation levels that did not show a change at
P3 (new) are indicated by a cross-hatched segment of the bar. Also indicated by differential shading are CGIs that were significantly altered at both P3
and P30, retaining or reversing their direction of change at P30 compared to P3 (retained direction; changed direction). (b) Hypermethylated and
hypomethylated promoter-associated CGIs at P3 and P30. For both ages, CGIs associated with promoters of neural tissue-specific genes (neural genes)
are represented by white bars, while CGIs associated with promoters of non-neural tissue-specific genes (housekeeping genes) are represented by
black bars. In addition, for P30, the number of CGIs with altered methylation state undetectable at P3 (new) and the number of CGIs corresponding to
the CGIs affected at P3, which either retained or reversed the direction of change (changed direction/retained direction), are indicated as in a. (c)
Abnormally methylated repetitive element-associated CGIs at P3 and P30.
doi:10.1371/journal.pone.0001919.g008
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essential for normal neurogenesis [67], dual specificity tyrosine (Y)-
phosphorylation-regulated kinase3 which is a cyclic-AMP/protein
kinase A-activated MAP kinase-related protein kinase implicated
in regulating cell growth [68], GATA-binding protein4 which is a
MAPK-activated zinc-finger-containing transcription factor in-
volved in cell differentiation [69–72], subunit 1 of general
transcription factor 3c which is a subunit of a polymerase III
transcription factor complex [73], inositol (myo)-1-monopho-
sphatase1 which dephosphorylates myo-inositol monophosphate
in the phosphatidylinositol signaling system [74], and microtubule-
associated protein 6, which is a neural-specific protein responsible
for axonal microtubular stability [75]. This broad range of the
targets of cocaine-induced alterations, and the crucial cellular
functions of these transcripts, demonstrate the depth and breadth
of the impact that chronic maternal cocaine exposure could exert
on offspring neuronal function in the hippocampus and probably
also in the cellular machinery of other tissues.
It is noteworthy that instances of both hypermethylation and
hypomethylation were observed following maternal cocaine
exposure. Generally, DNA CpG hypermethylation is thought to
result in decreased expression of the affected genes, whereas
hypomethylation could release the spatial constraints on access of
the transcriptional machinery to the regulatory sites of the gene;
this could thus enhance the chances of transcription of the gene
[3–9]. By mediating both effects, we can expect that some genes
would be activated while the expression of other genes would be
repressed by chronic maternal cocaine exposure. Quantitative
RT-PCR-based analysis of the expression levels of genes
corresponding to selected promoters that we had found to be
altered by cocaine exposure allowed us to test this notion in the
present model. Indeed, cocaine-induced hypermethylation of
several genes resulted in significant decrements of 5–15-fold in
the expression of these genes, whereas cocaine-induced promoter
hypomethylation caused significant increases of 4–19-fold in the
expression of the corresponding genes. This notwithstanding, some
genes, although showing altered methylation, did not demonstrate
changes in expression. Hence, unlike in behavioral studies where
cocaine is considered a psychostimulant, the genomic effects of
chronic cocaine exposure are profound and multidirectional, but
may not be simply predicted to be hypofunctional or hyperfunc-
tional in impact.
In contrast to our findings in neonatal animals where cocaine
exposure was associated with a decrease in global methylation
levels, overall DNA methylation was significantly elevated in the
P30 pups of cocaine-exposed mothers compared to matched
controls. When we more closely examined the methylation
patterns, various differences compared to the P3 animals were
evident. Some P3 hypermethylated or hypomethylated CGIs
remained as such, but newly hypermethylated or hypomethylated
targets were also uncovered. Most intriguing were those CGIs that
reversed the direction of response to cocaine at P30 compared to
P3. Either they were hypomethylated at P3 and became
hypermethylated at P30 or vice versa. One would have expected
that with passage of time there might be extinction of the effects
observed at P3, so that the DNA methylation states in the cocaine
group would generally begin to approach the levels in the controls.
At the present time it is not known if this reversal is an
overcompensation, or if it reflects a different developmental
trajectory initiated at birth or even in utero. Future studies could be
designed to systematically probe these issues.
Cocaine remains one of the most abused substances in the
Western hemisphere [76–80]. Maternal cocaine intake has been
associated with diverse immediate and long-term deleterious
effects on both the mother and the offspring [81]. While the
specific consequences of cocaine use by pregnant women are still
being debated [81–83], studies in several animal models have
demonstrated significant deficits in multiple aspects of nervous
system structure and function in the offspring of cocaine-exposed
mothers (e.g.: [81,84–86]. Considering that the epigenetic
machinery is potentially vulnerable to abnormal chemical
environments, it can be expected that one of the mechanisms by
which cocaine exposure could produce neuroteratological effects
might involve alterations in chromatin organization in neural cells.
Such alterations in chromatin may in turn derive from abnormal
states of DNA methylation induced by cocaine at various loci,
including the CGIs.
The mechanism by which cocaine induces alterations in DNA
methylation remains unknown. Classically, cocaine is thought to
exert its biological effects by interfering with presynaptic reuptake of
monoamine neurotransmitters from the synaptic cleft. The conse-
quent dramatic increases inthe synapticconcentrations of dopamine
or other monoamines thus elicits the behavioral effects, including the
motor,cardiovascular,andpsychologicaleffects[87].Dopamineand
other monoamines have been associated with teratological effects in
animals [88]. Existing data appear insufficient to establish or
discount a link between DNA methylation and the possible
teratological effects of the catecholamines. In the same vein, it
remains to bedeterminedifmaternalcocaine administration atthese
experimentaldosesisabletopenetrate theplacentalbarrierand alter
fetal brainmonoamine transmitterlevelssufficiently tomediate these
types of epigenetic alterations.
In summary, this study has demonstrated that maternal cocaine
exposure during the second and third trimesters of gestation results
in significant epigenomic alterations that are evident in the male
offspring around the perinatal and prepubertal periods. The
changes in hippocampal DNA methylation and gene expression
were not accompanied by observable differences in gross tissue
histology, overall quality of DNA, or even the litter sizes among
the cocaine and control groups. Notwithstanding any overt
structural differences, it is reasonable to speculate that the marked
alterations in the genomic apparatus associated with maternal
cocaine exposure could contribute to the disruption of neural and
behavioral functions observed in previous animal and human
cocaine studies.
Materials and Methods
Animals and cocaine treatment
Twenty timed pregnant CD1 dams (Charles River, Wilmington,
MA) were maintained in individual cages in a climate-controlled
room on a 12-h light/dark cycle. Ten randomly selected dams (the
cocaine-treatment group) were subcutaneously injected (at the
dorsum of the neck) with 20 mg/kg cocaine hydrochloride
(Research Technology Branch, National Institute on Drug Abuse,
Rockville, MD) dissolved in 200 ml of 0.9% saline, twice a day (at
8:00 AM and 8:00 PM) from the 8
th through the 19
th day of
gestation (E8–E19). Animals in the second set (saline-control
group) were subjected to the same schedule of injections but with
200 ml of 0.9% saline only. This model of prenatal cocaine
exposure has been successfully used in multiple studies by our
laboratory [89,90] and by other groups [85,91,92]. The period of
treatment was selected to start prior to the time of hippocampal
neurogenesis and ended at a time after all hippocampal pyramidal
neurons should have been generated and begun to assemble into
the pyramidal layer [93,94]. Throughout the treatment, all mice
were weighed daily. The control and treatment animals were pair-
fed such that the daily amount of food (Mouse Chow; Ralston
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matched to the amount consumed by the paired cocaine-treatment
dam. Water was available ad libitum. As previously demonstrated,
this feeding regimen resulted in similar weight gains from E8 to
E19 in both the treatment and control groups [90]. Animals were
allowed to deliver at term (,gestational day 20). From the time of
birth, each litter was fostered by an injection-naive surrogate dam
(from the same batch as the experimental animals) that had given
birth within the preceding 24–72 h. On day P3, two male pups
from each litter were identified based on anogenital distance [85].
The selected pups were deeply anesthetized with halothane and
following decapitation their brains were collected. In addition,
pieces of liver were dissected out to be used to verify the sex of the
animals by means of Mm01339632-s1 gene expression assay for
Sry sex-determining region of the Y chromosome (Applied
Biosystems, Foster City, CA). The assay confirmed that all the
selected pups were males. The rest of the pups in each litter were
allowed to survive until weaned (P21), after which the male pups
(identified by their genitalia) from each litter were housed in
groups of 2-3 per cage. At P30, one male per litter was deeply
anesthetized with halothane and following decapitation the brains
were collected. All procedures for animal housing and use in these
experiments were reviewed and approved by the University of
Maryland Animal Care and Use Committee and conformed to the
NIH Guide for the care and use of experimental animals.
Laser microdissection of hippocampal neurons
Brains collected from the pups were cut into left and right
hemispheres and immediately transferred to a sheet of aluminum
foil placed over dry ice. After 5 min, the frozen tissue was placed
in cryogenic vials and stored in a freezer at 280uC for a period not
exceeding 2 months before use. Each brain hemisphere was
initially cut into serial 12-mm-thick coronal sections using a Zeiss
cryostat (Carl Zeiss, Thornwood, NY). All sections containing the
hippocampus were mounted on sterile PEN foil-covered slides
(Leica Microsystems, Wetzlar, Germany), and the slides boxed
while still inside the cryostat and then transferred to a 280uC
freezer. Within 2 weeks of sectioning, slides were processed, in
groups of up to 20 at a time, for staining and microdissection. The
staining was conducted in an RNAse-free laminar flow hood and
included the following 30-sec steps: 57% ethanol, distilled water,
HistoGene stain (Arcturus, Mountain View, CA), distilled water,
75% ethanol, 95% ethanol, and 100% ethanol. After that, the
sections were air-dried for 30–60 min. Laser microdissection was
performed on a Leica ASLMD laser capture microdissection
system (Leica Microsystems, Wetzlar, Germany). All dissections
were executed by a single investigator who had no knowledge of
the group assignment of the samples. On every section, the
pyramidal layer, encompassing the C1, C2 and C3 hippocampal
regions, was identified based on Paxinos and Franklin [95] and
carefully cut out.
For the P3 animals, tissues obtained from the left hemispheres of
the two pups taken from each litter (20 male pups altogether) were
combined and used for investigating CGI methylation. Pyramidal
layer tissue from the right hemisphere of one of these brains was
used for analyzing gene expression. Tissues excised from every 5
th
section of the right hemisphere of the second brain were used for
estimation of total DNA content. The remainder of the laser-
excised hippocampal pyramidal tissue from these P3 pups was
used for evaluating global DNA methylation.
For the P30 animals, given that a single brain was selected per
litter, the laser-excised hippocampal pyramidal tissues from the left
hemisphere were pooled and used for assessing CGI methylation.
Pyramidal layer tissue cut out from every 10
th section of the right
hemisphere was used for measuring total DNA content, while
tissue from every 11th section was used for investigating gene
expression. The remainder of the excised hippocampal tissue from
the right hemisphere was used for determining global DNA
methylation.
During each run, we captured and saved 10X and 40X
microscope images before and after the laser microdissection of
each brain section from which the tissues for total DNA assay were
obtained. These images were later visually examined by two
histologists in order to assess potential qualitative histological
differences between cocaine-treatment and saline-control tissues
and to verify the precision of the laser cut.
Measurement of total DNA content in hippocampal
pyramidal tissue
In estimating the DNA content of the hippocampal pyramidal
layer of a hemisphere, we used the Cavalieri estimator as modified
by Reed and colleagues [96]. As described above, the 12-mm
sections used for DNA content estimation were selected by
systematic random sampling (every 5
th section in P3 mice and
every 10
th section in P30 animals). The amount of DNA in the
excised pyramidal layer from each section was assayed using
PicoGreen dsDNA quantitation kit (Invitrogen, Carlsbad, CA) and
the resulting fluorescence detected on a SuperMax Gemini XS
Spectrofluorometer (Molecular Devices, Sunnyvale, CA) at the
emission wavelength of 520 nm and 480 nm for excitation.
Salmon sperm DNA dilutions of known concentration served as
standards. Based on the obtained value (ai) from each examined
section, the total DNA content of the hippocampal pyramidal
layer in a hemisphere (WDNA) was calculated as follows:
WDNA~(tz1)
X n
i~1
ai
where n=number of sections examined, and t=number of non-
assayed sections occurring between the sections examined. The
precision of the data obtained for each animal was calculated as
the coefficient of error (CE) for the modified Cavalieri method
[96]. Statistical analyses included two-way ANOVA with maternal
treatment and age of the offspring as independent variables. The
ANOVA was followed by Tukey post hoc tests (Prism, GraphPad,
San Diego, CA). Significant differences were inferred at p ,0.05
or better.
Global DNA Methylation Assay
Tissue DNA was extracted using Puregene DNA isolation kit
(Gentra Systems, Minneapolis, MN) with glycogen added as a
carrier to assist in DNA precipitation. The extracted DNA was
quantified by PicoGreen dsDNA quantitation kit as described
above. For each sample, methylation analysis was performed in
triplicate aliquots (200 ng DNA each) using anti-methylated
cytosine antibody-based MethylAmp Global DNA methylation
quantification kit (Epigentek, New York, NY). We used methylated
DNA standards supplied with the kit, while for blanks we simply
omitted DNA from the assay. The spectroscopic end point (optical
density, OD) was read on an Opsys MR microplate reader
(Dynex, Chantilly, VA). After subtracting blank readings from the
readings for both the sample and the standard, the value of DNA
methylation for each sample was calculated as a ratio of sample
OD relative to the OD of the standard. The triplicate values
obtained for each tissue from each animal were averaged to give a
single data point for the tissue/animal. Statistical analysis was
conducted as described above for tissue DNA content.
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Methylation profiling analysis was performed using a modifica-
tion of the MeDIP (methylated DNA immunoprecipitation)
method of Weber and colleagues [97] combined with CGI
microarray hybridization. MeDIP was selected because the
methodology supports high-resolution and high-throughput
DNA methylation profiling, is sensitive to the overall number of
methylated cytosine residues in the regions of interest, and its
sensitivity is independent of the presence of recognition sites for
methylation-sensitive restrictases [97,98]. DNA was extracted as
described above for global methylation assay. The quantity and
quality of the extracted DNA was determined by NanoChip on
Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).
For all the samples, DNA fragments sized 100 kb or less
constituted ,87% of the total sample DNA, indicating that the
quality of the DNA was appropriate for CGI methylation analysis.
For the MeDIP procedure, pairs of 400 ng DNA samples from
cocaine-treated and saline-control tissues were incubated in
parallel with MseI (T/TAA) restrictase (New England Biolabs,
Ipswich, MA; 1 U,3 7 uC, overnight), which digests the bulk DNA
into smaller fragments but retains CGIs largely intact [29]. Upon
completion of the digestion, the DNA was purified with DNA
MinElute reaction cleanup kit (Quiagen, Valencia, CA) and
denatured for 10 min at 95uC. The denatured DNA was
incubated for 2 h at 4uC with 0.1 ml of anti-methylated cytosine
mouse monoclonal antibodies (Epigentek, New York, NY) in a
final volume of 500 ml immunoprecipitation (IP) buffer (compo-
sition: 10 mM sodium phosphate, 140 mM NaCl, 0.05% triton
X100, pH 7.4). The mixture was further incubated for 2 h at 4uC
in 30 ml of sheep anti-mouse IgG M280 Dynabeads (Invitrogen,
Carlsbad, CA). After washing three times with IP buffer, the beads
were treated with proteinase K (2 U; Invitrogen, Carlsbad, CA) for
3 h at 50uC. Methylated DNA was then recovered by use of the
MinElute reaction cleanup kit. The recovered DNA was processed
for random-primed Klenow amplification with Bioprime kit
(Invitrogen, Carlsbad, CA) in the presence of unmodified dNTPs
for 5–10 fold sensitivity improvement. After another MinElute
cleanup step, the DNA was labeled using 3DNA Array 900DNA
detection system (Genisphere, Hatfield, PA). Briefly, the DNA
fragments were tailed with dTTP and ligated with capture oligos
complementary to either Alexa 564-incorporating dendrimers (for
the saline-control samples) or Alexa 647-incorporating dendrimers
(for the cocaine-treatment samples). Pairs of these tagged saline-
control and cocaine-treatment samples were co-hybridized to a
glass CGI microarray containing 7,296 annotated clones (Micro-
array Center of the University Health Network, Toronto, ON,
Canada). For each array hybridization, the paired DNA samples
used were matched between pups of litters generated by pair-fed
saline-control and cocaine-treatment dams. Array hybridization was
carried out overnight at 65uC, after which the arrays were incubated
for 3 h at 65uC with a capture-reagent mixture containing both
Alexa 546-incorporating dendrimers and Alexa 647-incorporating
dendrimers.The arrayswerewashed and spin-driedina CentraCL3
centrifuge (Thermo Electron, Wyman, MA). For both P3 and P30
assays, DNA from each litter was used once for hybridization, hence
a total of ten P3 arrays and ten P30 arrays were processed. The
microarray data are available inMethDB database (www.metdb.de):
Sample ID21455-Experiment ID21524 (for P3 data) and Sample
ID21456-Experiment ID21525 (for P30 data).
Microarray slides were scanned at 10-mm resolution on a
GenePix 4100A scanner (Axon, Union City, CA), with the laser
excitation set at 532 nm (green emission filter 575DF35;
photomultiplier voltage 550) for the Alexa 546 (saline-control)
samples, while the laser excitation was switched to 635 nm (red
emission filter 670DF40; photomultiplier voltage 695) to obtain
readings for the Alexa 637 (cocaine-treatment) samples. The
signals were converted into high (16-bits-per-pixel) resolution
images, providing a color depth of 65,536 levels. Densitometric
quantitation was then conducted on the images using GenePix Pro
6.0 software (Axon, Union City, CA) with background subtraction.
Quality control utilized the 384 positive and 24 negative QC spots
present on the arrays. Intra-slide and inter-slide normalizations
(the latter being for slides hybridized with samples of the same pup
age) were performed by LOWESS transformation in Acuity 4.0
software (Axon, Union City, CA). Statistical analysis of the
normalized data was conducted based on the Significance Analysis
of Microarray (SAM) algorithm translated into Excel macros
(http://www-stat.stanford.edu/,tibs/SAM/). In the analysis, a
threshold was set to identify the maximum number of altered
CGIs at the minimal false discovery rate (FDR) indicated by SAM
for a given set of microarray data. For analysis of both P3 and P30
samples, the FDR rates were ,5%. CGIs revealing significantly
altered methylation levels were subjected to a BLAT search
(http://genome.ucsc.edu/cgi-bin/hgBlat) to identify their possible
affiliation with specific promoters, exons, introns, and/or repetitive
elements. The latter were recognized by the RepeatMasker
algorithm (http://www.repeatmasker.org).The neural tissue-specific
genes among the genes that were identified as linked to promoters
associated with abnormally methylated CGIs were detected with
PathwayAssist 3.0 software (Ariadne Genomics, Rockville, MD)
based on the Entrez Gene database (http://www.ncbi.nlm.nih.gov/
entrez/query.fcgi?CMD=Display&DB=gene) using the keywords:
neural, neuron, glia, synapse, axon, and dendrite.
To verify the linearity of MeDIP-based methylated DNA
detection, a source sample of hippocampal DNA was extracted
from a drug-naive adult mouse. Using 4 sets of primers designed
for the purpose, 4 amplicons were generated from the source DNA
to yield fragments that were close in length but containing
different numbers of CpGs. These fragments, named according to
the CpGmouse database (http://data.microarrays.ca/cpgmouse),
and their respective primers designed with GeneFisher (http://
bibiserv.techfak.uni-bielefeld.de/genefisher), are presented in
Table 1. The primers were synthesized by Applied Biosystems
(Foster City, CA). PCR amplification of the fragments was
conducted on a Sprint Thermal Cycler (Thermo Electron,
Wyman, MA) employing PCR MasterMix (Fermentas, Hanover,
MD). Cycle conditions (using PCR MasterMix) providing linear
and compatible amplification of the selected fragments were
predetermined to be: 94uC for 3 min; 94 cycles at 94uC for 30 sec;
52uC for Fr1, Fr2, and Fr3 and 48uC for Fr4 for 30 sec, and then
for all 72uC for 30 sec. Two hundred nanogram of DNA was used
for amplification of each fragment in 100 ml total volume. The
reaction mixture with each amplicon was electrophoresed on
ethidium bromide-stained 1.5% agarose gel followed by extraction
of the PCR product with QIAquick gel extraction kit (Qiagen,
Valencia, CA) and cloning these products using TOPO TA
Cloning kit (Invitrogen, Carlsbad, CA). Selected colonies were
checked for inserts by colony PCR with T7 and Sp6 primers
(Fermentas, Hanover, MD). After transformation, the cells were
grown on FastMedia LB-agar (Fermentas, Hanover, MD)
overnight at 37uC. For each fragment, 3 colonies were then
grown in 3 ml of FastMedia LB-liquid (Fermentas, Hanover, MD)
with agitation overnight at 37uC. Plasmid DNA was extracted with
Wizard plasmid DNA purification system (Promega, Madison,
WI). Sequencing of the extracted plasmids by Macrogen (Seoul,
South Korea) confirmed the predicted sequences of the DNA
fragments. Afterwards, each clone was amplified by PCR as
described earlier for the amplification of same fragments from the
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extraction, and 2 mg of each product was treated with SssI
methylase (New England Biolabs, Ipswitch, MA; 2 U for 1 h at
37uC) to methylate all CpGs present in the selected DNA
sequences. Methylated DNA was cleaned using Qiagen’s Mini-
Elute, and 400 ng DNA from each methylated clone, together
with 400 ng of unmodified DNA from Fr4 clones (selected because
Fr4 contained the highest number of CpGs), was subjected to the
MeDIP procedure. Following purification with Dynabeads, the
recovered DNA samples were used for PCR-based amplification
under the same conditions as described above (50 ml total volume).
One microliter from each of the amplified samples was run on an
ethidium bromide-stained 1.5% agarose gel. After electrophoresis,
images of the gels were digitized under UV light using a LAS 3000
Image Analyzer (Fuji, Edison, NJ), and the densitometric analysis
of the bands produced by the fragments of interest was performed
using Science Lab 2001 software (Fuji, Edison, NJ). A linear
regression fit of the data was achieved with KaleidaGraph
Software (Synergy, Reading, PA).
Bisulfite Sequencing
A detailed analysis of CpG methylation by bisulfite sequencing
was performed for ten selected promoters associated with CGIs for
which MeDIP/CGI array profiling had indicated significant
cocaine-induced alterations in their methylation state (hypomethy-
lation or hypermethylation at age P3). The promoter sequences
were obtained from the Transcriptional Regulatory Element
Database (http://rulai.cshl.edu/cgi-bin/TRED/tred.cgi?process=
home). For each of the ten P3 saline-control and cocaine-treatment
samples, 400 ng DNA was subjected to sodium bisulfite treatment
using EZ DNA Methylation-Gold kit (Zymo Research, Orange CA).
The C-to-T conversion was conducted for 10 min at 98uCa n dt h e n
for 2.5 h at 64uC in a Sprint thermal cycler (Thermo Electron,
Wyman, MA). The converted DNA was cleaned using Zymo-Spin
IC columns, and then subjected to nested PCR amplification.
Primers for each promoter (Table 3) were designed using
MethPrimer (http://urogene.org/methprimer/index1.html) and
synthesized by Applied Biosystems. The amplification procedure
was performed in a total volume of 50 ml employing PCR
MasterMix (Fermentas). For both the first and second steps of the
nested PCR, the conditions were: 94uC for 2 min, 30 cycles at 94uC
for 30 sec followed by 55–62uC (depending on the primers) for
1m i n , a n d 7 2 uC for 1 min. The PCR products were electro-
phoresed on ethidium bromide-stained 1.5% agarose gels, and
extracted using Qiagen’s QIAquick kit. Extracted DNA fragments
wereclonedand3clonesofeachfragmentofinterestforeachsample
DNA were collected as described above. For each clone, the plasmid
DNA was extracted with Wizard plasmid DNA purification system
(Promega) and sequenced by Macrogen (Seoul, South Korea).
Detection of methylated cytosine in cloned sequences (3 clones per
sequence per sample) was performed using BiQ Analyzer software
(http://bioinf.mpi-sb.mpg.de/projects/biq-analyzer/index.html).
The percentage of methylated CpGs in each cloned sequence
was calculated, with the values from parallel sequences
generated from the same DNA sample averaged to generate a
single data point. Statistical analysis of the data was performed
by GeneSpring software (Agilent, Palo Alto, CA) using two-
tailed t-tests with the FDR multiple testing error correction set
at the p cut-off value of 0.05.
To verify that there were no methylation-associated biases
during the PCR amplification procedures we screened each set of
nested primers according to the technique of Warnecke and
colleagues [99] with slight modifications. Essentially, we evaluated
the methylation levels of sequences obtained from bisulfite
conversion of the tested primers using serial mixtures of DNA
samples obtained from hippocampal tissues of two adult male
mice, one from a saline-control litter and the other from a cocaine-
treatment litter. The mixing started with 0% and ended with
100% of the DNA from the saline-control animal. For all the
primer sets, the increase in the recovered methylated CpGs was
linear (data not shown), indicating the absence of significant bias
among the samples.
Quantitative Real-Time RT-PCR
Real-time PCR was conducted to analyze the expression of
DNMTs in P3 and P30 tissues, and also to evaluate the expression
of genes associated with the promoters examined by bisulfite
sequencing as described above. RNA was extracted from
designated tissues by RNeasy Micro kit (Qiagen, Valencia CA).
To remove genomic DNA contamination, the isolated RNA was
treated with amplification grade DNAse I (1 U/ mg RNA;
Invitrogen, Carlsbad, CA) for 15 min at 25uC. The quantity and
quality of the obtained DNA were determined by NanoChip on an
Agilent 2100 Bioanalyzer. All RNA samples used showed a 28S to
18S ratio .1.5 and the absence of low molecular weight smears.
Reverse transcription was performed with Qiagen’s Omniscript
RT kit using random hexamers as primers (20 ml of RT reaction
reagent/1 mg RNA). Real-time PCR utilized TaqMan approach
with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) or ß-
actin employed as endogenous controls. The TaqMan PCR
primers and probes (Table 3) were designed using Primer Express
1.5a (Applied Biosystems) and synthesized by Applied Biosystems.
The PCR reactions were carried out on an ABI Prism 7700
Sequence Detector (Applied Biosystems). All PCR reactions were
run in a monoplex mode–amplification of one gene per reaction
well in a PCR plate. Each reaction included 1 ml cDNA in a total
volume of 50 ml and used TaqMan Universal Master Mix (Applied
Biosystems). Cycling parameters were: 95uC for 10 min, followed
by 45 cycles of 95uC for 15 sec and 60uC for 1 min. Assays were
performed in triplicate, and the values averaged to obtain one
datum per sample. Procedures for normalization to internal
standards and for expression of the resultant data were according
to the amplification plot method of Peirson and colleagues [100] as
implemented in DART-PCR Excel workbook (http://www.
gene-quantification.info/bestkeeper.html). Amplification efficien-
cies for both target and control genes were calculated from the raw
data around the midpoint of the transformed signal range, an
approach that is thought to be more accurate than if derived from
an external standard curve [101]. Our ‘‘standard cDNA’’ used for
efficiency calculations was generated from a ‘‘standard’’ hippo-
campal tissue obtained from a drug-naive adult male mouse. To
assess possible contamination with chromosomal DNA, several
RNA samples were processed for PCR with GAPDH probe and
primers without the RT step. In each case, no amplification
products were detected. Gene expression data obtained with use of
GAPDH or ß-actin as internal standards were separately analyzed
with similar conclusions reached. Multiple parallel t-tests were
conducted to compare corresponding P3 and P30 data. All
comparisons were based on 10 saline-treated and 10 cocaine-
treated samples, with statistical significance inferred at p,0.05 or
better.
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